Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;68(2):120-126.
doi: 10.1007/s00105-016-3927-7.

[Melasma : An update on the clinical picture, treatment, and prevention]

[Article in German]
S Becker  1 , C Schiekofer  2 , T Vogt  2 , J Reichrath  2
Affiliations
Review

[Melasma : An update on the clinical picture, treatment, and prevention]

[Article in German]
S Becker et al. Hautarzt. 2017 Feb.

Abstract

Melasma, also known as chloasma or mask of pregnancy, presents clinically as hyperpigmented skin areas, which develop mostly in the face as a consequence of increased synthesis of melanin. The established treatment options, including topically applied agents and the use of various laser systems, mostly result in improvement but not in complete remission of the lesions. Because of its significant impact on quality of life and the limited effectivity of available treatment options, the management of melasma is challenging for the treating physician. Although many risk factors, including pregnancy and UV exposure, have been identified, the pathogenesis is not yet fully understood. Avoiding solar or artificial UV exposure is of high importance both for the prevention of melasma and for the clinical outcome of existing lesions. In order to avoid vitamin D deficiency, oral vitamin D supplementation should be recommended. In this review, we give an update on clinical aspects, epidemiology, pathogenesis and therapy of melasma and give an outlook on future developments.

Keywords: Hyperpigmentation; Pregnancy; Sunlight; UV exposure; Vitamin D.

PubMed Disclaimer

Similar articles

  • Melasma: insights and perspectives.
    Jadotte YT, Schwartz RA. Jadotte YT, et al. Acta Dermatovenerol Croat. 2010;18(2):124-9. Acta Dermatovenerol Croat. 2010. PMID: 20624364 Review.
  • Hyperpigmentation and melasma.
    Rigopoulos D, Gregoriou S, Katsambas A. Rigopoulos D, et al. J Cosmet Dermatol. 2007 Sep;6(3):195-202. doi: 10.1111/j.1473-2165.2007.00321.x. J Cosmet Dermatol. 2007. PMID: 17760699 Review.
  • An Update on New and Existing Treatments for the Management of Melasma.
    Gan C, Rodrigues M. Gan C, et al. Am J Clin Dermatol. 2024 Sep;25(5):717-733. doi: 10.1007/s40257-024-00863-2. Epub 2024 Jun 19. Am J Clin Dermatol. 2024. PMID: 38896402 Free PMC article. Review.
  • [Acne and rosacea in pregnancy].
    Bechstein SK, Ochsendorf F. Bechstein SK, et al. Hautarzt. 2017 Feb;68(2):111-119. doi: 10.1007/s00105-016-3918-8. Hautarzt. 2017. PMID: 28070633 Review. German.
  • Melasma: treatment strategy.
    Sehgal VN, Verma P, Srivastava G, Aggarwal AK, Verma S. Sehgal VN, et al. J Cosmet Laser Ther. 2011 Dec;13(6):265-79. doi: 10.3109/14764172.2011.630088. J Cosmet Laser Ther. 2011. PMID: 21981383 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. FASEB J. 2007 Apr;21(4):976-94 - PubMed
    1. Ann Dermatol. 2010 Nov;22(4):373-8 - PubMed
    1. Am J Dermatopathol. 2010 Oct;32(7):676-82 - PubMed
    1. Br J Dermatol. 2003 Sep;149(3):572-7 - PubMed
    1. Int J Dermatol. 2003 Dec;42(12 ):966-72 - PubMed

LinkOut - more resources